4d Molecular Therapeutics
Clinical trials sponsored by 4d Molecular Therapeutics, explained in plain language.
-
One shot to save sight? gene therapy aims to replace monthly eye injections
Disease control Recruiting nowThis trial is testing a one-time gene therapy injection, called 4D-150, for adults with wet age-related macular degeneration (AMD) who currently need regular eye injections to protect their vision. The main goal is to see if this single treatment can safely reduce or eliminate th…
Phase: PHASE1, PHASE2 • Sponsor: 4D Molecular Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Inhaled gene therapy offers new hope for cystic fibrosis patients
Disease control Recruiting nowThis trial is testing a new inhaled gene therapy called 4D-710 for adults with cystic fibrosis lung disease. It's specifically for people who can't use or don't respond well to current standard treatments. The study will check if the single-dose treatment is safe and if it helps …
Phase: PHASE2 • Sponsor: 4D Molecular Therapeutics • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
One-Shot vision treatment could replace yearly eye injections
Disease control Recruiting nowThis trial is testing a new, one-time eye injection called 4D-150 for adults with wet age-related macular degeneration (AMD), a leading cause of vision loss. The main goal is to see if this single treatment can control the disease and maintain vision for up to two years, potentia…
Phase: PHASE3 • Sponsor: 4D Molecular Therapeutics • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC